Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 181 - SPECIAL HEALTH PROGRAMS
Chapter 2 - SCREENING OF INFANTS FOR INHERITED AND CONGENITAL INFANT OR CHILDHOOD-ON SET DISEASES
Section 181-2-003 - SPECIFICATION OF DISEASES

Current through September 17, 2024

All infants born in the state of Nebraska must be tested for the diseases identified in Neb. Rev. Stat. § 71-519 and the following diseases:

(A) Argininosuccinic Acidemia;

(B) Beta-ketothiolase Deficiency;

(C) Carnitine Uptake Defect;

(D) Citrullinemia;

(E) Congenital Adrenal Hyperplasia;

(F) Cystic Fibrosis;

(G) Glutaric Acidemia type 1;

(H) Homocystinuria;

(I) Isovaleric Acidemia;

(J) Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency;

(K) Maple Syrup Urine Disease;

(L) Methylmalonic Acidemia (Mutase Deficiency);

(M) Methylmalonic Acidemia (Cbl A and B);

(N) Multiple Carboxylase Deficiency;

(O) Propionic Acidemia;

(P) Severe Combined Immune Deficiencies;

(Q) Tyrosinemia;

(R) Trifunctional Protein Deficiency;

(S) Very Long-chain Acyl-CoA Dehydrogenase Deficiency;

(T) 3-Hydroxy 3-Methyl Glutaric Aciduria; and

(U) 3-Methylcrotonyl-CoA Carboxylase Deficiency.

Disclaimer: These regulations may not be the most recent version. Nebraska may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.